Articlenpj women's health2026

Combination of oxidative phosphorylation and platelet-derived growth factor inhibitors for the treatment of ovarian cancers.

Kathleen M Burkhard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.